Herbalife Ltd Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
19.2%projected annual EPS growth
Analyst Coverage
3analysts covering
FY Revenue (est.)
$5.3Bnext fiscal year
FY EPS (est.)
$2.37next fiscal year
Monitoring Framework
Key Performance Indicators
Net Sales Growth (Constant Currency) Quarterly540.0%Target: 1.5% to 5.5% (Full-Year 2026 Guidance)
Adjusted EBITDA (Reported) Quarterly175.7MTarget: $675 million to $705 million (Full-Year 2026 Guidance)
Total Leverage Ratio Quarterly2.7xTarget: Further reduction from 2.7x
Watch Items
- China Market Net Sales RecoveryTrigger: Double-digit year-over-year sales decline (e.g., -12% in Q1 2026)Action: Monitor local distributor engagement, promotional adjustments, and localized product launches to reverse the downward trend.
- Personalization Ecosystem IntegrationTrigger: Integration milestones of Bioniq, Pro2col, Link BioSciences, Pruvit, and the 'Fuel Like Ronaldo' campaignAction: Track active user adoption rates of the Pro2col beta platform and subsequent sales performance of personalized nutrition products.
Research as of 20 Jun 2026